- Home
- ZLAB vs CBZ Comparison
ZLAB vs CBZ Comparison
Compare ZLAB & CBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- CBZ
- Stock Information
- Founded
- ZLAB 2013
- CBZ 1987
- Country
- ZLAB China
- CBZ United States
- Employees
- ZLAB N/A
- CBZ N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- CBZ Business Services
- Sector
- ZLAB Health Care
- CBZ Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- CBZ Nasdaq
- Market Cap
- ZLAB 3.6B
- CBZ 4.0B
- IPO Year
- ZLAB 2017
- CBZ N/A
- Fundamental
- Price
- ZLAB $32.54
- CBZ $72.19
- Analyst Decision
- ZLAB Buy
- CBZ Strong Buy
- Analyst Count
- ZLAB 5
- CBZ 1
- Target Price
- ZLAB $54.28
- CBZ $86.00
- AVG Volume (30 Days)
- ZLAB 782.4K
- CBZ 542.5K
- Earning Date
- ZLAB 08-05-2025
- CBZ 07-30-2025
- Dividend Yield
- ZLAB N/A
- CBZ N/A
- EPS Growth
- ZLAB N/A
- CBZ N/A
- EPS
- ZLAB N/A
- CBZ 1.55
- Revenue
- ZLAB $418,326,000.00
- CBZ $2,157,189,000.00
- Revenue This Year
- ZLAB $44.07
- CBZ $58.65
- Revenue Next Year
- ZLAB $49.13
- CBZ $5.74
- P/E Ratio
- ZLAB N/A
- CBZ $46.76
- Revenue Growth
- ZLAB 43.72
- CBZ 32.27
- 52 Week Low
- ZLAB $16.01
- CBZ $62.66
- 52 Week High
- ZLAB $44.34
- CBZ $90.13
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- CBZ 51.40
- Support Level
- ZLAB $34.26
- CBZ $70.04
- Resistance Level
- ZLAB $35.72
- CBZ $74.04
- Average True Range (ATR)
- ZLAB 1.12
- CBZ 1.84
- MACD
- ZLAB -0.54
- CBZ 0.26
- Stochastic Oscillator
- ZLAB 3.83
- CBZ 71.89
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.